Science

Valuable insights from a new article on Unresectable Stage IIIA/IIIB NSCLC – IU Simon Comprehensive Cancer Center

IU Simon Comprehensive Cancer Center/LinkedIn

Jan 7, 2025, 14:28

Valuable insights from a new article on Unresectable Stage IIIA/IIIB NSCLC – IU Simon Comprehensive Cancer Center

IU Simon Comprehensive Cancer Center shared a post on LinkedIn about a recent paper by Michael Weisman et al. published in International Journal of Radiation Oncology, Biology, Physics:

“Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer”

Authors: Michael Weisman, Greg Durm, Misty Dawn Shields, Nasser Hanna, Sandra Althouse, Tim Lautenschlaeger.

Valuable insights from a new article on Unresectable Stage IIIA/IIIB NSCLC - IU Simon Comprehensive Cancer Center

“Gain valuable insights from a new article published in the International Journal of Radiation Oncology, Biology, Physics by the cancer center’s Greg Durm, MD, Misty D. Shields, MD, PhD, Nasser H. Hanna, MD, Tim Lautenschlaeger, MD, and colleagues.”

More posts featuring IU Simon Comprehensive Cancer Center.

cancer Greg Durm ipilimumab IU Simon Comprehensive Cancer Center Michael Weisman Misty Dawn Shields Nasser Hanna nivolumab non small cell lung cancer NSCLC OncoDaily Oncology Sandra Althouse Tim Lautenschlaeger

ACT for Children: Tackling Inequities in Childhood Cancer Through Unique Global Collaboration

Richard Gere and Alejandra Gere to Join Second Global OncoThon on February 15 for Fight Against Childhood Cancer

Mesothelioma Guideline Updates from ASCO 2024: Key Advances in Diagnosis and Treatment

Oncologist Near Me - Lynn Schuchter: A Pioneering Leader in Cancer Care and Melanoma Research

NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%